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Abstract
AIM: To investigate the risk association of xeroderma 
pigmentosum group C (XPC) Lys939Gln polymorphism 
alone and in combination with cigarette smoking on 
colorectal cancer (CRC) predisposition. 
METHODS: Peripheral blood samples of 510 study 
subjects (255 CRC patients, 255 controls)were collect-
ed. DNA was extracted and genotyping was performed 
using polymerase chain reaction-restriction fragment 
length polymorphism. The association between poly-
morphic genotype and CRC predisposition was deter-
mined using the OR and 95%CI. 
RESULTS: The frequency of the homozygous variant 
(Gln/Gln) genotype was significantly higher in cases 
compared with controls (16.0% vs  10.2%, P  = 0.049). 
The Gln/Gln genotype of XPC  showed a significantly 
higher association with the risk of CRC (OR = 1.884; 
95%CI: 1.082-3.277; P  = 0.025). In the case of allele 
frequencies, variant allele C was associated with a sig-
nificantly increased risk of CRC (OR = 1.375; 95%CI: 
1.050-1.802; P  = 0.020). Moreover, the risk was mark-
edly higher for those who were carriers of the Gln/Gln 
variant genotype and were also cigarette smokers (OR 
= 3.409; 95%CI: 1.061-10.949; P  = 0.032). 
CONCLUSION: The XPC Gln/Gln genotype alone and 
in combination with smoking increases the risk of CRC 
among Malaysians.
© 2013 Baishideng. All rights reserved.
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INTRODUCTION
Colorectal cancer (CRC) is a major public health problem 
worldwide, being the third most common cancer and the 
fourth most common cancer causing death[1]. In Malaysia, 
CRC has become the most common cancer among males 
and the second most common among females[2]. The 
development of  CRC is a complex, multistep process 
involving interaction between environmental and genetic 
factors. Environmental factors such as dietary and life-
style habits, smoking, alcohol consumption, and obesity 
interact with host’s genetic factors, especially genetic 
variations, and may modulate the risk of  CRC[3]. Genetic 
variations, such as single nucleotide polymorphisms 
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carcinogens and may act as cancer predisposition factors. 
Environmentally sensitive genetic polymorphisms acting 
together with environmental factors are well documented 
candidates influencing cancer susceptibility.
DNA damage repair genes maintain the integrity of  
the genome against endogenous and exogenous factors. 
The xeroderma pigmentosum group C (XPC) gene is a 
DNA repair gene involved in the nucleotide excision re-
pair (NER) mechanism which repairs bulky DNA lesions 
such as pyrimidine dimers, ultraviolet light-induced dam-
age, photoproducts, intrastrand crosslinks, larger chemi-
cal adducts and other genotoxic agents[4]. Genetic varia-
tions in the XPC gene have been reported to modulate 
an individual’s susceptibility to developing cancer[5,6]. The 
XPC Lys939Gln polymorphism, which leads to an amino 
acid change from lysine to glutamine at codon 939, is the 
most common SNP studied in the XPC gene and has 
been shown to be associated with increased risk of  sever-
al cancers such as skin[7], breast[8] and bladder cancers[9,10].
However, there are only limited reports on the asso-
ciation of  this polymorphism with CRC susceptibility. A 
case-control study was undertaken in order to investigate 
the association of  this polymorphism alone and also in 
conjunction with cigarette smoking on the risk of  CRC. 
This polymorphism is believed to alter the gene expres-
sion and modulate the DNA repair function of  the pro-
tein product, as it is located at the coding sequence of  the 
XPC gene. Thus, we hypothesized that XPC Lys939Gln 
polymorphism may have an effect on modulating the 
susceptibility to CRC, and cigarette smoking may further 
enhance the effect on CRC risk.
MATERIALS AND METHODS
Study subjects
The study was approved by the Research Review Board 
and Ethics Committee of  Universiti Sains Malaysia, 
Kelantan and the Ministry of  Health, Malaysia. For this 
hospital-based case control study, subjects were recruited 
from various hospitals in Malaysia, including Hospital 
Universiti Sains Malaysia, Hospital Raja Perempuan 
Zainab II and Hospital Sultanah Bahiyah, Kedah, Malay-
sia. Genotyping was carried out at the Human Genome 
Center, Universiti Sains Malaysia. Two hundred and fifty 
five sporadic CRC patients and 255 healthy normal con-
trols were recruited as study subjects. Cases were histopa-
tologically confirmed sporadic CRC patients, aged > 25 
years, who did not have previous colon/rectal or other 
cancers. Cases with known (as indicated in the pathology 
reports) familial adenomatous polyposis, ulcerative colitis 
or Crohn’s disease or any other previous malignancy were 
excluded. Controls were normal healthy individuals who 
were biologically unrelated to the study patients, aged > 
25 years and had no history of  cancer. Epidemiological 
data was collected from patients using a pre-structured 
questionnaire, which included sociodemographic status, 
physical status, dietary factors, occupation, tobacco/alco-
hol habits, previous illness, radiation exposure, etc.
Genotyping
Genotyping of  XPC Lys939Gln polymorphism was car-
ried out using polymerase chain reaction (PCR)-restriction 
fragment length polymorphism. Briefly, PCR primers for 
XPC Lys939Gln (F: 5’-GGCTTCCTGGTATCTGAT-
TACT-3’R: 5’-CTCAGTTTGCCTTCTCAGCA-3’) were 
used to generate a 402 bp product containing the poly-
morphic site. The PCR reactions were carried out in a 25 
µL volume of  1 × PCR Buffer, 2.0 mmol/L of  MgCl2, 0.5 
mmol/L dNTPs, 0.4 mmol/L of  each primers and 1 U of  
AmpliTaq Gold Polymerase with a denaturation of  94 ℃ 
for 5 min, followed by 35 cycles at 94 ℃ for 30 s, 57 ℃ for 
30 s, 72 ℃ for 30 s and finally 5 min at 72 ℃. Following 
amplification, the PCR products were digested using PvuII 
restriction enzyme for 1 h at 37 ℃ and electrophoresed 
on 2% agarose gel. The homozygous wild-type genotype 
was identified by a single band at 402 bp level, the hetero-
zygous genotype by 3 bands at 402, 276 and 126 bp levels 
and the homozygous variant by 2 bands at 276 and 126 
bp levels (Figure 1).
Statistical analysis
The sample size was calculated with power and sample 
size (PS) software version 2.1.31 using the uncorrected χ 2 
test with 80% power and 95%CI. The difference in distri-
bution of  genotypes, gender and age between cases and 
controls were assessed using the χ 2 test. The ORs and 
95%CI were calculated using binary logistic regression to 
evaluate the risk association. All statistical tests were two-
sided, and statistical significance was determined as P < 
0.05. SPSS v.18 (SPSS Inc., Chicago, IL, United States) 
was utilized for statistical analysis.
RESULTS
The demographic characteristics of  the study subjects 
are shown in Table 1. This case-control study recruited 
510 study subjects, including 255 histopathologically con-
firmed sporadic CRC patients and 255 healthy normal 
controls. Of  the 255 CRC patients, 139 (54.5%) were 
male and 116 (45.5%) were female. Of  the 255 normal 
controls, 115 (45.1%) were male and 140 (54.9%) were 
female. The ages of  the sporadic CRC patients ranged 
from 27 to 93 years (mean age: 53.17 ± 7.07 years) and 
of  the healthy normal controls ranged from 26 to 84 
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Figure 1  Gel picture showing the different categories of xeroderma pig-
mentosum group C Lys939Gln polymorphism genotype. Lane M: 100 bp 
DNA ladder; Lanes 2 and 3: Homozygous wildtype; Lane 1: Heterozygous; 
Lanes 4 and 5: Homozygous variant.  
years (mean age: 46.47 ± 12.02 years). 
The frequencies of  the homozygous wildtype (Lys/
Lys), heterozygous (Lys/Gln) and homozygous variant 
(Gln/Gln) genotypes were 108 (42.4%), 106 (41.6%) and 
41 (16.0%), respectively, among CRC cases. In controls, 
the frequencies were 129 (50.6%) for homozygous wild-
type, 100 (39.2%) for heterozygous and 26 (10.2%) for 
homozygous variant genotypes. The frequency of  the ho-
mozygous variant (CC) genotype was significantly higher 
in cases compared with the controls (P = 0.049). Table 2 
shows the genotype and allele frequencies of  XPC Lys-
939Gln polymorphism in cases and controls.
Binary logistic regression analysis was performed in 
order to find the risk association. Table 3 shows the as-
sociation between the XPC Lys939Gln polymorphism 
and risk of  CRC. It can be clearly seen that the homozy-
gous variant genotype was significantly associated with 
increased risk of  CRC (OR = 1.884; 95%CI: 1.082-3.277; 
P = 0.025). The variant allele C was found to be signifi-
cantly associated with increased risk of  CRC (OR = 1.375; 
95%CI: 1.050-1.802; P = 0.020). Furthermore, the study 
subjects were stratified into smokers and non-smokers 
and the risk association was evaluated. Results showed 
that, for those with the homozygous variant genotype 
(CC) and who were smokers, the risk was significantly 
increased (OR = 3.409; 95%CI: 1.061-10.949; P = 0.032). 
In the non-smoking group, no significant association was 
observed between the XPC Lys939Gln polymorphism 
and the risk of  CRC.
DISCUSSION
To date, a variety of  chemical carcinogens have been 
identified to cause DNA damage in humans. DNA dam-
age repair genes are responsible for maintaining the 
integrity of  the human genome through different path-
ways, locations and types of  damage by base excision 
repair, NER, double strand break and mismatch repair 
pathways[4]. Genes involved in the NER pathway, such 
as XPC, commonly repair lesions induced by numerous 
exogenous agents such as those derived from food and 
smoking, including 2-amino-1-methyl-6-phenylimidazo-
[4,5-β]-pyridine and benzo-[α]-pyrenediol-epoxide[11].
The XPC gene, located on chromosome 3p25, con-
tains 16 exons and 15 introns and encodes a 940 amino 
acid protein[12]. Several polymorphic variants in the XPC 
gene have been identified and XPC Lys939Gln is one of  
the three most common SNPs. This case-control study 
investigated the genotype and allele frequencies of  the 
XPC Lys939Gln polymorphism, and the risk association 
with sporadic CRC susceptibility. Results from the pres-
ent study showed that the frequency of  the XPC homo-
zygous variant genotype was significantly higher in cases 
compared with controls (16.0% vs 10.2%, P = 0.049). 
On evaluation of  the risk association, the homozygous 
variant genotype (CC) was associated with significantly 
increased risk of  CRC (OR = 3.409; P = 0.032). This 
result conforms with a study by Yasuda et al[13], which 
demonstrated that a single amino acid alteration could 
be sufficient to compromise XPC function, thereby en-
hancing the risk of  CRC development. Our results are in 
agreement with a few other reports by Qiu et al[5], Zhang 
et al[6] and Gil et al[14] which revealed that XPC is one the 
most important genes modulating an individual’s risk of  
developing sporadic cancer.
Carcinogens consumed through dietary and lifestyle 
habits as well as from the environment play a major role 
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Table 1  Demographic characteristics of the study population 
n  (%)
Variable Cases (n  = 255 ) Controls (n  = 255) P -value
Gender
   Male 139 (54.5) 115 (45.1)    0.0341
   Female 116 (45.5) 140 (54.9)
Mean age (yr) 53.17 ± 7.07 46.47 ± 12.02   0.086
Cigarette smoking
   Yes 110   48 < 0.0011
   No 145 207
1Statistically significant.
Table 2  Genotype and allele frequencies of the xeroderma 
pigmentosum group CLys939Gln polymorphism in study 
subjects  n  (%)
Cases (n  = 255) Controls (n  = 255) P -value
Genotype
   Homozygous 
wildtype (AA)
108 (42.4) 129 (50.6) 0.062
   Heterozygous (AC) 106 (41.6) 100 (39.2) 0.588
   Homozygous 
variant (CC)
  41 (16.0)   26 (10.2)  0.0491
Allele
   A 322 (63.1) 358 (70.0) 0.294
   C 188 (36.9) 152 (30.0)
1Statistically significant.
Table 3  Xeroderma pigmentosum group C Lys939Gln 
polymorphism, smoking and colorectal cancer susceptibility 
risk
Cases Controls OR (95%CI) P -value
Genotype
   Lys/Lys (AA) 108 129      1 (Reference)1
   Lys/Gln (AC) 106 100 1.266 (0.871–1.841) 0.216
   Gln/Gln (CC)    41    26 1.884 (1.082–3.277)  0.0252
Allele
   A 322 358      1 (Reference)1 -
   C 188 152 1.375 (1.050–1.802)  0.0202
Non-smoker
   AA    64 104      1 (Reference)1
   AC    64    81 1.284 (0.817–2.018) 0.278
   CC    17    22 1.256 (0.620–2.542) 0.526
Smoker
   AA    44    25      1 (Reference)1
   AC    42    19 1.256 (0.605–2.609) 0.541
   CC    24       4   3.409 (1.061–10.949)  0.0322
1Homozygous wildtype genotype served as the reference category; 
2Statistically significant. 
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845 controls, showed that the homozygous variant (CC) 
genotype was significantly associated with higher risk of  
CRC in a Chinese population (OR =1.5; 95%CI: 1.0-2.2; 
P = 0.035). Moreover, combination (AC + CC) genotypes 
in the homozygous wildtype model also showed a sig-
nificant association with risk of  CRC (OR = 1.3; 95%CI: 
1.0-1.7; P = 0.039). When the study subjects were strati-
fied into tea drinkers and non-tea drinkers, the results 
showed that individuals who were non-tea drinkers and 
carried combination (AC + CC) genotypes, had increased 
risk of  CRC (OR = 3.0; 95%CI: 1.9-4.7; P < 0.001).
Apart from CRC, XPC polymorphism was reported 
to be associated with the risk of  other cancers, such as 
head and neck[25], lung[10], breast[8] and bladder[26]. In ad-
dition, abnormal expression of  the XPC gene has been 
shown in hepatocarcinogenesis[27]. The variant allele of  
the XPC gene is associated with lower DNA repair ca-
pacity (DRC). Several studies showed that the Lys939Gln 
polymorphism had an interaction with other SNPs locat-
ed in the same gene, such as Ala499Val, PAT (-/+) and 
IVS11 C/A polymorphisms. According to Khan et al[28], 
the XPC Lys939Gln polymorphism is in linkage disequi-
librium with the XPC PAT polymorphism as well as the 
C/A polymorphism at 25 positions of  intron 11 of  XPC. 
This causes exon 12 to be skipped and deleted, resulting 
in the loss of  XPC cDNA function, thus reducing the 
DNA repair activity.
Researchers have shown that carriers of  the C variant 
allele of  the XPC Lys939Gln polymorphism exhibited 
significantly more DNA damage induced by BPDE[21,29,30]. 
Moreover, combinations of  haplotype C + C (Lys939Gln, 
PAT +, Ala499Val) have been reported to cause poor 
DRC, thus increasing the risk of  CRC. In contrast, haplo-
type T-A (Ala499Val-PAT-Lys939Gln) has been demon-
strated to be associated with the least DNA damage[21,24]. 
Also, another study has shown that accumulation or the 
presence of  alleles in the XPC gene associated with in-
creased risk might reduce DRC and thus increase CRC 
susceptibility[31].
The difference in results on the risk association be-
tween the present study and other previous studies might 
be explained by differences in genetic background of  
study subjects groups or populations, and also differences 
in exposure to environmental and lifestyle factors. Small 
sample sizes and/or inadequate control for certain con-
founder factors such as gender and age might also have 
contributed to the differing results and lack of  associa-
tion. 
From the present study, it is reasonable to suggest 
that the XPC gene, especially the XPC variant genotype, 
may modulate the DRC of  the host cell and thus play an 
important role in sporadic colorectal carcinogenesis. The 
risk could be much higher in individuals who possess 
the variant genotype and who are also cigarette smokers. 
The results also highlight the potential role of  the NER 
pathway (especially of  XPC) in modulation of  an indi-
vidual’s risk of  sporadic CRC. Further studies to explore 
the interaction of  XPC Lys939Gln with other SNPs of  
in damaging DNA. Cigarette smoking is one of  the life-
style factors that play an important role in the exposure 
of  an individual to the carcinogens present in cigarette 
smoke. Carcinogens contained in tobacco smoke, such as 
polycyclic aromatic hydrocarbons, heterocyclic amines, 
nitrosamines and aromatic amines, are harmful to the 
human colon and rectum. Cigarette smoking has been 
reported to lead to the formation of  DNA adducts and 
cause damage to the DNA in the human colon[15,16]. 
All these carcinogens can reach the colorectal mucosa, 
through direct ingestion or via the circulatory system, and 
has been demonstrated to induce bulky adducts in crypt 
cells and contribute to the formation of  mutations in the 
colon[17,18]. In the present study, a combination of  smok-
ing and a variant genotype of  XPC enhanced the risk of  
CRC 3-fold, indicating that smoking further enhanced 
the risk of  CRC. Although non-smokers showed an OR 
of  1.256, this was not statistically significant.
The XPC gene encodes an important protein involved 
in the recognition of  DNA damage in the NER pathway. 
This protein binds to HR23B protein to form XPC-
HR23B that recognizes a DNA lesion and repairs the 
DNA damage along with other DNA repair proteins[19,20]. 
Polymorphism in the coding sequence of  the XPC gene 
has been demonstrated to alter the gene expression and 
thereby modulate the DNA repair function[21]. The XPC 
Lys939Gln polymorphism is located in the coding se-
quence of  the XPC gene. The nucleotide change from 
A to C leads to an amino acid change from lysine to 
glutamine in the coding sequence of  the XPC gene and 
has been reported to lead to reduced repair capacity. This 
genetic variation has also been reported to result in re-
duced specificity of  this gene in recognition and repair of  
the DNA damage as well as in protein expression, thus 
allowing more somatic DNA mutations or alterations to 
occur[21,22].
The XPC protein plays a crucial role in repairing the 
DNA damage caused by tobacco smoke. Individuals with 
the XPC variant genotype may possess deficient DNA 
repair capability. Accordingly, the XPC protein product 
may be less efficient in repairing the DNA lesions in-
duced by tobacco smoke, and thereby could enhance the 
susceptibility, favoring the development of  CRC.
Previous studies focusing on the role of  the XPC 
variant in the modulation of  an individual’s risk of  de-
veloping CRC are scarce, and reported results are incon-
sistent. Berndt et al[22], in an American population, found 
an OR of  1.19 for the variant genotype’s association with 
risk of  CRC, but the result was statistically insignificant (P 
= 0.50). In contrast, a study conducted by Hansen et al[23], 
in a Polish population, observed no significant risk asso-
ciation between this polymorphism and CRC susceptibil-
ity. However, when the variant genotype in conjunction 
with red meat consumption was evaluated, the risk was 
reported to be significantly higher (OR = 3.7) in those 
who carried the homozygous variant (CC) genotype and 
consumed 100 g red meat per day.
A recent study by Wu et al[24] on 421 CRC patients and 
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the XPC gene and with other genes involved in DNA 
repair pathways, either singly or in combination, and to 
examine the correlation with environmental factors such 
as alcohol consumption and dietary habits, as well as 
clinicopathological characteristics, would be beneficial in 
deriving more accurate risk predictive markers.
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Background
Colorectal cancer (CRC) which is the most common cancer among males and 
the second most common among females in Malaysia, has become a major 
public problem. Environmental factors, such as dietary carcinogens and to-
bacco smoke, interacting with the host’s genetic factors may modulate the risk 
of CRC. However, the genetic predisposition factors associated with colorectal 
carcinogenesis remain largely undetermined. Identification of the host’s genetic 
predisposition factors may help in understanding the carcinogenic process. 
Thus, it was of interest to explore the contribution of single nucleotide polymor-
phisms (SNPs) in a DNA repair gene, alone and in combination with tobacco 
smoke, as a predisposition factor for CRC susceptibility. 
Research frontiers
Exposure to mutagens and carcinogens through diet, tobacco smoke,etc can 
cause varying degrees of DNA damage and can cause mutations in humans 
if left unrepaired. The xeroderma pigmentosum group C (XPC) gene is a DNA 
repair gene involved in the nucleotide excision repair (NER) pathway. The 
SNP, Lys939Gln, located at the coding region of the XPC gene has been as-
sociated with lower DNA repair capacity and has been shown to be associated 
with increased risk of cancers of the skin, breast and bladder. This study was 
designed to determine the frequencies and influence of the XPC Lys939Gln 
polymorphic genotype, alone and in combination with smoking, on sporadic 
CRC susceptibility risk in a Malaysian population.
Innovations and breakthroughs
Only limited reports are available on the association of XPC Lys939Gln poly-
morphism with CRC susceptibility risk. To the best of our knowledge, this is the 
first report of an association between the genetic variant of XPC with CRC sus-
ceptibility risk in the Malaysian population. The observation that genetic varia-
tion of the XPC gene influences susceptibility to CRC implies the importance 
of the NER pathway in modulation of an individual’s risk of CRC. This study 
provides support for the hypothesis that genetic variation in the XPC gene, act-
ing together with environmental factors, contributes to CRC development and 
may be considered as a candidate marker for CRC predisposition risk in the 
Malaysian population.
Applications
The present study observed that the genetic variation Lys939Gln of the XPC 
gene influences the risk of CRC in the Malaysian population. Further SNP 
mapping studies utilizing high throughout genotyping methods could facilitate 
the analysis of multiple polymorphisms within DNA repair genes. Genotyping 
of Malaysian CRC patients for polymorphism(s) in DNA repair genes will help 
in understanding the specific polymorphism(s), which act as predisposing 
genotype(s) in CRC susceptibility. In future, the study can be extended to a 
population level, to identify individuals with high risk predisposition genotypes. 
Appropriate surveillance programs could then be developed in order to reduce 
the morbidity and mortality of CRC at the population level.
Peer review
This case-control study investigated the association between SNPs and ciga-
rette smoking on sporadic CRC susceptibility risk in Malaysian population. The 
genotype and allele frequencies of XPC Lys939Gln were investigated in 255 
CRC patients and 255 healthy controls. Homozygous variant (CC) genotype 
frequency was found to be significantly higher in CRC cases compared to con-
trols. When the risk association was evaluated singly, the homozygous variant 
XPC CC genotype was associated with an increased risk of CRC susceptibility. 
Moreover, when the risk was evaluated after stratifying the study subjects into 
smokers and non-smokers, the combination of smoking habits and variant gen-
otype of XPC was found to enhance the CRC susceptibility risk to 3-fold times 
higher. These results prompt us to suggest that genetic variation Lys939Gln 
in XPC gene might modify the effect of smoking and contribute to sporadic 
colorectal cancer etiology.
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